Chronic spontaneous urticaria (CSU) pathogenesis shows a complex and still unclear
interplay between immunoglobulin (Ig) G-and IgE-mediated autoimmunity, leading to mast …

Quite a few patients with chronic spontaneous urticaria (CSU) are refractory to H 1-
antihistamines, even though the dose of H 1-antihistamines is increased up to 4-fold. CSU …

Omalizumab is an anti-IgE humanized monoclonal antibody approved for the treatment of
severe asthma and chronic spontaneous urticaria. Omalizumab binds free serum IgE and …

Background: The real-life data on the effectiveness and safety of omalizumab in chronic
spontaneous urticaria (CSU) with validated methods are scarce. There is also a lack of …

Background About one-half of all patients with chronic spontaneous urticaria have low or
less reactivity of the basophils to FcωRI stimulation. However, the differences in the clinical …

Urticaria is a poorly understood and underestimated clinical condition characterised by the
sudden onset of itchy wheals and/or angioedema, which usually resolve within 24 and 72 …

Background Omalizumab is approved for the treatment of chronic spontaneous urticaria
(CSU) not responding to antihistamines. Data on omalizumab use in real-world settings and …

Хроническая крапивница (ХК)–заболевание, ха-рактеризующееся появлением
уртикарных элементов сыпи и (или) ангиоотеков, которые сохраняются в течение> 6 …

Abstract Purpose of the Review Omalizumab has become the mainstay of the treatment of
severe CSU, but a subset of patients seems completely unresponsive to the drug. This …

Хроническая спонтанная крапивница (ХСК) распространенное заболевание кожи, при
котором волдыри и/или ангиоотеки появляются без видимой причины и сохраняются не …